How Hospitals Can Blunt the Effects of Tariffs
Artificial intelligence (AI) and advanced analytics can assist hospitals as they endure the uncertainty caused by tariffs.
Artificial intelligence (AI) and advanced analytics can assist hospitals as they endure the uncertainty caused by tariffs.
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall.
Alan Murray on improving access for medical transportation.
Time is of the essence, particularly for those with cognitive conditions. The loss of telehealth flexibilities, combined with disruptions to Medicaid, could have devastating consequences for millions of patients with dementia and other cognitive and behavioral conditions.
CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five years. However, experts believe the program will not be enough to stabilize the finances of rural hospitals — especially in the face of worsening reimbursement issues, an ongoing workforce crisis and billions of dollars’ worth of Medicaid cuts on the horizon.
Clinging to our old models is equivalent to waiting for failure. We need to embrace the tools, team structures, and delivery models that this ongoing crisis demands.
Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce crisis, especially in rural areas, by making it prohibitively expensive for hospitals to hire international clinicians. Critics are also worried that the change could slow the pace of healthcare innovation by discouraging foreign workers from contributing to the tech and research sectors in the U.S.
Healthcare and life sciences are about to face unprecedented AI-driven regulatory changes that will reshape everything from research and development to drug approval submissions. Here are 10 steps healthcare and life sciences organizations should take to strategically prepare.
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions.
Premature claims about Tylenol and autism put politics ahead of science and risk eroding the public trust essential to health.
There are aspects of the plan worth praising, but these benefits are overshadowed by three key concerns that will disproportionately impact vulnerable populations if the plan is implemented as written.
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility.
In the race to modernize US healthcare, Donald Trump’s new health data-sharing initiative risks giving Big Tech a stranglehold over patient information, and locking out the very startups that fuel innovation.
Here's a roadmap that brings together a wide range of existing and new initiatives under four key goals that enable community-based organizations to take stock of their existing capabilities and coordinate across them effectively.
At the heart of this fight are the patients whose lives quite literally depend on Medicaid. But we are also fighting for the caregivers who show up every day, the children who rely on stability, the families who rally around their loved ones, and all those whose lives are shaped by access to care.
The One Big Beautiful Bill Act has drawn criticism from healthcare groups for slashing Medicaid and ACA subsidies, but it contains a few provisions that could drive progress.